Cancer Antigen 125 Serum Level in Head and Neck Diffuse Large B-Cell Lymphoma
Background: Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of the Non-Hodgkin Lymphoma (LNH). Until now, lactate dehydrogenase (LDH) is the only tumor marker to assess DLBCL progression; however, increased LDH is a relatively non-specific biomarker. Cancer antigen 125 (CA-125) seru...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Padjadjaran
2020-06-01
|
Series: | Althea Medical Journal |
Subjects: | |
Online Access: | http://journal.fk.unpad.ac.id/index.php/amj/article/view/1788 |